The Human Papillomavirus (HPV) and Cytomegalovirus (CMV) therapeutics industry focuses on developing vaccines and antiviral treatments to prevent and manage infections. Rising awareness, advanced therapies, and increasing demand for personalized and preventive healthcare solutions are driving growth in this industry globally. HPV & CMV Therapeutics Market Overview The HPV and CMV therapeutics market is evolving rapidly, with multiple strategic trends shaping its growth trajectory from 2026 through 2034. Rising prevalence of HPV and CMV infections, technological advancements in treatment options, and increasing public health awareness are driving demand for innovative therapeutics. Market players are adopting forward-looking strategies to capitalize on emerging opportunities, improve patient outcomes, and strengthen their global presence. The HPV and CMV therapeutics market is segmented by drug type and application. HPV therapeutics includ...